Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - XENONICS HOLDINGS, INC.Financial_Report.xls
EX-31.1 - EX-31.1 - XENONICS HOLDINGS, INC.d342058dex311.htm
EX-32.1 - EX-32.1 - XENONICS HOLDINGS, INC.d342058dex321.htm
EX-32.2 - EX-32.2 - XENONICS HOLDINGS, INC.d342058dex322.htm
EX-31.2 - EX-31.2 - XENONICS HOLDINGS, INC.d342058dex312.htm
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number: 001-32469

 

 

XENONICS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   84-1433854
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

3186 Lionshead Avenue

Carlsbad, California

  92010
(Address of principal executive offices)   (Zip code)

(760) 477-8900

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨    Smaller Reporting Company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

The registrant had 24,975,929 shares of common stock outstanding as of August 3, 2012.

 

 

 


Table of Contents

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION   
Item 1.  

Financial Statements

  
 

Condensed Consolidated Balance Sheets as of June 30, 2012 (unaudited) and September 30, 2011

     1   
 

Condensed Consolidated Statements of Operations for the Three and Nine Months ended June  30, 2012 and 2011 (unaudited)

     2   
 

Condensed Consolidated Statements of Cash Flows for the Nine Months ended June  30, 2012 and 2011 (unaudited)

     3   
 

Notes to Unaudited Condensed Consolidated Financial Statements

     4   
Item 2.  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     10   
Item 3.  

Quantitative and Qualitative Disclosures About Market Risk

     13   
Item 4.  

Controls and Procedures

     13   
PART II. OTHER INFORMATION   
Item 6.  

Exhibits

     14   

SIGNATURES

     15   

EXHIBIT 31.1

  

EXHIBIT 31.2

  

EXHIBIT 32.1

  

EXHIBIT 32.2

  

 

i


Table of Contents

PART I. FINANCIAL INFORMATION

 

ITEM 1. Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

 

     June 30,
2012
    September 30,
2011
 

Rounded in thousands, except par value

   (unaudited)        

Assets

    

Current Assets:

    

Cash

   $ 302,000      $ 738,000   

Accounts receivable

     325,000        273,000   

Inventories

     2,226,000        2,542,000   

Other current assets

     190,000        144,000   
  

 

 

   

 

 

 

Total Current Assets

     3,043,000        3,697,000   

Equipment, furniture and fixtures at cost, less accumulated depreciation of $170,000 and $160,000

     17,000        35,000   

Goodwill

     375,000        375,000   

Other assets

     42,000        116,000   
  

 

 

   

 

 

 

Total Assets

   $ 3,477,000      $ 4,223,000   
  

 

 

   

 

 

 

Liabilities and Shareholders’ Equity

    

Current Liabilities:

    

Accounts payable

   $ 433,000      $ 414,000   

Accrued expenses

     111,000        99,000   

Accrued payroll and related taxes

     84,000        96,000   

Notes payable, net of debt discount

     1,522,000        —     
  

 

 

   

 

 

 

Total Current Liabilities

     2,150,000        609,000   

Notes payable, net of debt discount

     —          459,000   
  

 

 

   

 

 

 

Total Liabilities

     2,150,000        1,068,000   
  

 

 

   

 

 

 

Commitments and contingencies (Note 11)

    

Shareholders’ Equity:

    

Preferred shares, $0.001 par value, 5,000,000 shares authorized, 0 shares issued and outstanding

     —          —     

Common shares, $0.001 par value, 50,000,000 shares authorized as of June 30, 2012 and September 30, 2011; 24,976,000 shares issued and outstanding as of June 30, 2012 and September 30, 2011

     25,000        25,000   

Additional paid-in capital

     26,681,000        26,652,000   

Accumulated deficit

     (25,379,000     (23,522,000
  

 

 

   

 

 

 

Total Shareholders’ Equity

     1,327,000        3,155,000   
  

 

 

   

 

 

 

Total Liabilities and Shareholders’ Equity

   $ 3,477,000      $ 4,223,000   
  

 

 

   

 

 

 

See notes to unaudited condensed consolidated financial statements.

 

1


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

     Three months ended
June 30,
    Nine months ended
June 30,
 
     2012     2011     2012     2011  

Rounded in thousands, except per share amounts

   (unaudited)     (unaudited)  

Revenues

   $ 403,000      $ 775,000      $ 1,200,000      $ 6,323,000   

Cost of goods sold

     254,000        537,000        741,000        3,463,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     149,000        238,000        459,000        2,860,000   

Selling, general and administrative

     527,000        601,000        1,587,000        1,878,000   

Research and development

     191,000        198,000        588,000        495,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations

     (569,000     (561,000     (1,716,000     487,000   

Other income/(expense):

        

Interest income

     —          2,000        —          5,000   

Interest (expense)

     (61,000     (38,000     (139,000     (113,000
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before provision for income taxes

     (630,000     (597,000     (1,855,000     379,000   

Income tax provision

     —          —          2,000        2,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (630,000   $ (597,000   $ (1,857,000   $ 377,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share:

        

Basic

   $ (0.03   $ (0.02   $ (0.07   $ 0.02   

Fully-diluted

   $ (0.03   $ (0.02   $ (0.07   $ 0.02   

Weighted average shares outstanding:

        

Basic

     24,976,000        25,088,000        24,976,000        25,107,000   

Fully-diluted

    
24,976,000
  
    25,088,000        24,976,000        25,107,000   

See notes to unaudited condensed consolidated financial statements

 

2


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      Nine months ended
June 30,
 
     2012     2011  

Rounded in thousands

   (unaudited)  

Cash flows from operating activities:

    

Net income (loss)

   $ (1,857,000   $ 377,000   

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

    

Depreciation

     17,000        25,000   

Provision for bad debts

     (2,000     (36,000

Non-cash compensation for warrants issued and modified

     30,000        4,000   

Non-cash compensation to consultants

     74,000        75,000   

Amortization of warrants for notes payable

     62,000        62,000   

Changes in operating assets and liabilities:

    

Accounts receivable

     (50,000     313,000   

Inventories

     316,000        (157,000

Other current assets

     (46,000     (156,000

Accounts payable

     19,000        (346,000

Accrued expenses

     13,000        (43,000

Accrued payroll and related taxes

     (12,000     22,000   
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     (1,436,000     140,000   
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from notes payable

     1,000,000        —     

Purchase of common stock

     —          (106,000
  

 

 

   

 

 

 

Net cash provided by financing activities

     1,000,000        (106,000
  

 

 

   

 

 

 

Net increase (decrease) in cash

     (436,000     34,000   

Cash, beginning of period

     738,000        705,000   
  

 

 

   

 

 

 

Cash, end of period

   $ 302 ,000      $ 739,000   
  

 

 

   

 

 

 

Supplemental cash flow information:

    

Cash paid during the period for income taxes

   $ 2,000      $ 2,000   

Cash paid during the period for interest

   $ 101,000      $ 51,000   

See notes to unaudited condensed consolidated financial statements.

 

3


Table of Contents

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Rounded in thousands)

 

1. BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These financial statements and notes thereto should be read in conjunction with the financial statements and notes thereto for the year ended September 30, 2011 included in the Xenonics Holdings, Inc. (“Holdings”) Form 10-K filing. The results for the interim period are not necessarily indicative of the results for the full fiscal year.

The condensed consolidated financial statements include the accounts of Holdings and its wholly-owned subsidiary, Xenonics, Inc. (“Xenonics”), collectively, the “Company”.

 

2. GOING CONCERN

The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. At this time the Company has not yet received pending substantial purchase orders for its products to cover their operating costs and meet its obligations as they become due, which raises doubt about its ability to continue as a going concern.

The future of the Company as an operating business will depend on its ability to (1) obtain purchase orders and ship its products, (2) collect for shipments in a timely manner, (3) continue to exercise tight cost controls to conserve cash and attain profitable operations, and (4) obtain sufficient financing as may be required to sustain its operations.

The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. If the Company is unable to obtain adequate revenues and financing, it could be forced to cease operations.

 

3. RECENT ACCOUNTING PRONOUNCEMENTS

In January 2010, FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures About Fair Value Measurements. The ASU requires new disclosures about transfers into and out of Levels 1 and 2 and separate disclosures about purchases, sales, issuances, and settlements relating to Level 3 measurements. It also clarifies existing fair value disclosures about the level of disaggregation of disclosed assets and liabilities, and about inputs and valuation techniques used to measure fair value for both recurring and nonrecurring fair value measurements that fall in either Level 2 or Level 3. The new disclosures and clarifications of existing disclosures were effective, and adopted, during the Company’s second quarter ended March 31, 2010, however the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 measurements, were effective for the Company’s first quarter ending December 31, 2011. Other than requiring additional disclosures, the full adoption of this new guidance did not have a material impact on our consolidated financial statements.

In May 2011, the FASB issued ASU 2011-04 to amend the wording used to describe many of the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurement to (1) clarify the application of existing fair value measurement requirements and

 

4


Table of Contents

(2) change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The primary purpose of the amendments is to achieve common fair value measurement and disclosure requirements in U.S. GAAP and IFRS. The amendments in ASU 2011-04 are to be applied prospectively for interim and annual periods beginning after December 15, 2011. Adoption of this new guidance did not have a material impact on the Company’s consolidated financial statements.

In September 2011, the FASB issued ASU 2011-08 to amend and simplify tests for goodwill impairment by permitting an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a two-step goodwill impairment test. The amendments in ASU 2011-08 are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Adoption of this new guidance is not expected to have a material impact on the Company’s consolidated financial statements.

 

4. EARNINGS (LOSS) PER SHARE

Earnings (loss) per share is computed by dividing the income available to common shareholders by the weighted average number of common shares outstanding. Diluted earnings per share is computed similarly to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential additional common shares that were dilutive had been issued. Common share equivalents are excluded from the computation if their effect is anti-dilutive. The Company’s common share equivalents consist of stock options and warrants.

The diluted earnings per share did not include the dilutive effect, if any, from the potential exercise of stock options and warrants outstanding using the treasury stock method, because the exercise prices for all of the stock options and warrants outstanding was greater than the average stock price for the period. For the three and nine months ended June 30, 2012, the number of stock options and warrants excluded was 6,243,000. For the three and nine months ended June 30, 2011, the number of stock options and warrants excluded was 7,453,000.

 

5. INVENTORIES

 

Inventories were comprised of :    June 30,
2012
     September 30,
2011
 
     (unaudited)     

 

 

Raw materials

   $ 1,263,000       $ 1,126,000   

Work in process

     203,000         282,000   

Finished goods

     760,000         1,134,000   
  

 

 

    

 

 

 
   $ 2,226,000       $ 2,542,000   
  

 

 

    

 

 

 

 

6. USE OF ESTIMATES

The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

7. NOTES PAYABLE

On July 15, 2009 the Company borrowed $525,000 under the terms of promissory notes due July 15, 2012 with interest only payments due quarterly at an annual rate of 13%. The notes could have been prepaid without penalty on or after January 15, 2010.

 

5


Table of Contents

In connection with the notes payable transaction, the Company granted and issued 525,000 warrants with an exercise price of $0.75 and valued the warrants at $250,000 using the Black-Scholes option-pricing model and the following assumptions: the market price was $0.68, the volatility was estimated at 104%, the life of the warrants was 5 years, the risk free rate was 2.06% and the dividend yield was 0%. The value assigned for the warrants issued in conjunction with the notes payable was recorded as debt discount and is being amortized over the three year life of the notes. Pursuant to the terms of the promissory notes, the exercise price for the warrants was adjusted to $0.65 in April 2010 when the Company issued warrants at that lower price in connection with a stock offering. The Company recorded a valuation adjustment in 2010 of $6,000 for this change in the exercise price. For the three months ended June 30, 2012 and 2011 the Company recorded amortization of $21,000 and $21,000, respectively. For the nine months ended June 30, 2012 and 2011 the Company recorded amortization of $62,000 and $62,000, respectively.

On December 7, 2011 the Company and the holders of the promissory notes agreed to amend the due date to October 15, 2012. In conjunction with the amendment, the Company amended the warrants issued with the original notes to lower the exercise price from $0.65 per share to $0.40 per share. The Company evaluated these amendments under ASC 470-50, Debt-Modification and Extinguishment, and concluded that the amendments were not significant and were therefore treated as debt modifications.

On March 19, 2012 the Company borrowed $500,000 under the terms of a promissory note. Repayment of the promissory note is secured by a first lien security interest in all of the Company’s assets and is due no later than December 31, 2012, subject to earlier repayment upon the Company’s receipt of purchase orders. A total of $50,000 of interest must be paid on the loan.

On May 22, 2012 the Company borrowed $500,000 under the terms of a promissory note. Repayment of the promissory note is due no later than December 31, 2012, subject to earlier repayment upon the Company’s receipt of purchase orders. A total of $50,000 of interest was prepaid on the loan and will be amortized over the term of the loan.

 

Notes Payable    June 30,
2012
     September 30,
2011
 

Unsecured notes payable, maturing in October 2012, bearing interest at 13% per annum (net of unamortized debt discount of $3,000 as of June 30, 2012 and $66,000 as of September 30, 2011)

   $ 522,000       $ 459,000   

Secured note payable maturing in December 2012 bearing interest of $50,000

     500,000         —     

Purchase order note payable maturing in December 2012 bearing interest of $50,000

     500,000         —     
  

 

 

    

 

 

 

Total short term debt obligations

   $ 1,522,000       $ 459,000   
  

 

 

    

 

 

 

Future payments under short-term obligations as of June 30, 2012 are as follows:

 

2013

   $ 1,525,000   
  

 

 

 

Total

   $ 1,525,000   
  

 

 

 

 

6


Table of Contents
8. STOCK BASED COMPENSATION

Stock Options - US GAAP requires that compensation cost relating to share-based payment arrangements be recognized in the financial statements. US GAAP requires measurement of compensation cost for all employee share-based awards at fair value on date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes valuation model. Such fair value is recognized as expense over the service period, net of estimated forfeitures.

US GAAP requires that equity instruments issued to non-employees in exchange for services be valued at the more accurate of the fair value of the services provided or the fair value of the equity instruments issued. For equity instruments issued that are subject to a required service period the expense associated with the equity instruments is recorded as the instruments vest or the services are provided. The Company has granted options and warrants to non-employees and recorded the fair value of these equity instruments on the date of issuance using the Black-Scholes valuation model. The Company has granted stock to non-employees for services and values the stock at the more reliable of the market value on the date of issuance or the value of the services provided. For grants subject to vesting or service requirements, expenses are deferred and recognized over the more appropriate of the vesting period, or as services are provided.

In July 2003, the Company’s board of directors adopted a stock option plan. Under the 2003 option plan, options to purchase up to 1,500,000 shares of common stock are available for employees, directors, and outside consultants.

In December 2004, the Company’s board of directors adopted a 2004 stock incentive plan. The Company may issue up to 1,500,000 shares of common stock under the 2004 plan and no person may be granted awards during any twelve-month period that cover more than 300,000 shares of common stock.

The fair value of each option award is estimated on the date of grant using the Black-Scholes valuation model. There were no options granted in the nine months ended June 30, 2012 and 2011.

Expected volatility is determined based on historical volatility. Expected life is determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards and vesting schedules. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. Share-based compensation expense recognized is based on the options ultimately expected to vest. US GAAP requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimated. Forfeitures were estimated based on the Company’s historical experiences.

A summary of the Company’s stock option activity as of June 30, 2012, and changes during the nine months then ended is presented below:

 

     Stock
Options
     Weighted
Average
Exercise Price
     Weighted
Average
Contractual
Term (Years)
     Aggregate
Intrinsic Value  *
 

Outstanding at October 1, 2011

     805,000       $ 0.73         2.30      

Granted

     —           —           

Exercised

     —           —           

Forfeited, Expired or Cancelled

     —           —           
  

 

 

          

Outstanding at June 30, 2012

     805,000       $ 0.73         1.55       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Exercisable at June 30, 2012

     805,000       $ 0.73         1.55       $ —  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

* The aggregate intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The market value of our stock was $0.23 at June 30, 2012.

 

7


Table of Contents

There were no non-vested stock options as of June 30, 2012.

There was no compensation expense related to outstanding options for the three and nine months ended June 30, 2012 and 2011.

Stock warrants – The Company recognizes the value of stock warrants issued based upon an option-pricing model at their fair value as an expense over the period in which the grants vest from the measurement date, which is the date when the number of warrants, their exercise price and other terms became certain.

At June 30, 2012 and 2011, 5,438,000 and 6,648,000 warrants were outstanding and 5,131,000 and 5,962,000 warrants were vested, respectively.

On March 19, 2012 the Company agreed (1) to reduce the exercise price of warrants to purchase a total of 525,000 shares of the Company’s common stock from $0.40 to $0.285 per share and (2) to extend the expiration date of those warrants from July 15, 2014 to July 15, 2017. The Company also agreed (1) to reduce the exercise price of warrants to purchase a total of 99,000 shares of the Company’s common stock from an average exercise price of $3.00 to $0.285 per share and (2) to extend the expiration date of those warrants from September 21, 2012 to September 21, 2017. On April 19, 2012 the Company agreed to reduce the exercise price of warrants to purchase a total of 100,000 shares of the Company’s common stock from $0.90 to $0.285 per share.

In conjunction with the warrant modifications on March 19, 2012, the Company recorded compensation expense of $27,000. In conjunction with the warrant modifications on April 19, 2012, the Company recorded compensation expense of $3,000.

Compensation expense related to outstanding warrants for the three months ended June 30, 2012 was $3,000. Compensation expense related to outstanding warrants for the nine months ended June 30, 2012 was $30,000. There was no compensation expense related to outstanding warrants for the three months ended June 30, 2011. For the nine months ended June 30, 2011 compensation expense related to outstanding warrants was $4,000.

Common stock – On October 10, 2009 the Company issued 300,000 shares of unregistered common stock to an independent firm for investor relations, financial public relations and marketing services for a period of three years. The total value of the common stock issued was $240,000, of which $80,000 was recorded in Other current assets and $142,000 was recorded in Other assets. On April 28, 2010 the Company issued 300,000 shares to the same independent firm for an additional year for investor relations, financial public relations and marketing services. The total value of the common stock issued was $147,000, of which $43,000 was recorded in Other current assets and $104,000 was recorded in Other assets. For the three and nine months ended June 30, 2012, $25,000 and $74,000, respectively, was recorded as selling, general and administrative expense compared to $25,000 and $74,000 for the three and nine months ended June 30, 2011.

On December 6, 2010, in connection with the resignation of a director, the Company purchased and retired all 533,529 of its common shares owned by the director for a total price of $106,000 or $0.20 per share.

 

9. INCOME TAXES

The Company made a comprehensive review of its portfolio of uncertain tax positions in accordance with recognition standards established for certain tax positions. In this regard, an uncertain tax position represents the Company’s expected treatment of a tax position taken in a filed

 

8


Table of Contents

tax return, or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. As of June 30, 2012 and September 30, 2011, the Company does not have a liability for unrecognized tax benefits. The Company concluded that at this time there are no uncertain tax positions. As of June 30, 2012, the Company does not expect any material changes to unrecognized tax positions within the next twelve months.

The Company recognizes the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Judgment is required in assessing the future tax consequences of events that have been recognized in our financial statements or tax returns. Fluctuations in the actual outcome of these future tax consequences could materially impact our financial position or our results of operations. For the three months ended June 30, 2012, deferred income tax assets and the corresponding valuation allowance increased by $812,000.

The Company’s 2012 provision for income taxes primarily relates to state taxes. The difference between the Company’s 2012 effective rate and statutory rate is primarily due to the use of federal net operating losses to offset taxable income. The difference between the Company’s 2011 effective rate and statutory rate is primarily due to the utilization of net operating losses.

 

10. FAIR VALUE OF FINANCIAL INSTRUMENTS

The FASB accounting guidance requires disclosure of fair value information about financial instruments, whether or not recognized in the accompanying consolidated balance sheets. Fair value as defined by the guidance is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value estimates of financial instruments are not necessarily indicative of the amounts we might pay or receive in actual market transactions. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. Effective April 1, 2008 the Company adopted and follows ASC 820, Fair Value Measurements and Disclosures (“ASC 820”) which established a fair value hierarchy that requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instruments categorization within the hierarchy is based on the lowest level of input that is significant to the fair value measurement.

The Company’s cash and cash equivalents are measured at fair value in the Company’s consolidated financial statements and are valued using unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 inputs under ASC 820). The carrying amount of our accounts receivable, accounts payable and accrued expenses reported in the consolidated balance sheets approximates fair value because of the short maturity of those instruments. The fair value of the notes payable is estimated based on current rates offered to the Company for similar debt of the same remaining maturities.

At June 30, 2012 and September 30, 2011, we did not have any material applicable nonrecurring measurements of nonfinancial assets and nonfinancial liabilities.

 

11. COMMITMENTS AND CONTINGENCIES

The Company is occasionally subject to legal proceedings and claims that arise in the ordinary course of business. It is impossible to predict with any certainty the outcome of pending disputes, and management cannot predict whether any liability arising from pending claims and litigation will be material in relation to the Company’s consolidated financial position or results of operations.

 

12. GOODWILL

The $375,000 recorded as goodwill represents the excess of the purchase price over the recorded minority interest of the Xenonics common stock repurchased as of December 10, 2009. The Company does not amortize goodwill. Instead, the Company evaluates goodwill annually in the fourth quarter and whenever events or changes in circumstances indicate that it is more likely than not that an impairment loss has been incurred. As of June 30, 2012, the Company determined that no such impairment indicators exist.

 

13. SUBSEQUENT EVENTS

Management evaluated all activity through the date that the consolidated financial statements were issued, and concluded that no subsequent events have occurred that would require recognition in the condensed consolidated financial statements or disclosure in the notes to the condensed consolidated financial statements.

 

9


Table of Contents
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (rounded in thousands)

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying notes filed as part of this report.

Forward-Looking Statements

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations, as well as information contained elsewhere in this report, contain statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements include statements regarding the intent, belief or current expectations of us, our directors or our officers with respect to, among other things: anticipated financial or operating results, financial projections, business prospects, future product performance and other matters that are not historical facts. The success of our business operations is dependent on factors such as the impact of competitive products, product development, commercialization and technology difficulties, the results of financing efforts and the effectiveness of our marketing strategies, general competitive and economic conditions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those projected in the forward-looking statements as a result of various factors, including as a result of the factors described in the “Risk Factors” section of our most recent Annual Report on Form 10-K. We do not undertake any obligation to update or revise any forward-looking statements contained in this report, whether as a result of new information, future events or otherwise.

Results of Operations

Three-months ended June 30, 2012 compared to the three-months ended June 30, 2011

We operate in the security lighting systems and night vision industries, and the majority of our revenues are derived from sales of our illumination products and our SuperVision night vision product to various customers.

Revenues: Revenues for the quarter ended June 30, 2012 were $403,000 compared to revenues of $775,000 for the quarter ended June 30, 2011. In the quarter ended June 30, 2012, 86% of revenues were from sales of our NightHunter products to the military (U.S. Army, U.S. Marines and military distributors). In the quarter ended June 30, 2011, 94% of revenues were from sales of our NightHunter products to the military.

Cost of Goods and Gross Profit: Cost of goods consist of the cost of manufacturing our NightHunter One and SuperVision products and the price that we pay to Excelitas Technologies (formerly PerkinElmer) for NightHunter 3 products that Excelitas Technologies manufactures for us.

The gross profit percentages were 37% and 31% for the quarters ended June 30, 2012 and 2011, respectively.

Selling, General and Administrative: Selling, general and administrative expenses decreased by $74,000 to $527,000 for the quarter ended June 30, 2012 as compared to $601,000 for the quarter ended June 30, 2011. The decrease is primarily attributed to the reductions in compensation and benefits of $37,000, consulting services of $20,000 and marketing and sales expenses of $16,000.

Research & Development: Research and development expenses decreased by $7,000 to $191,000 for the quarter ended June 30, 2012 compared to $198,000 for the quarter ended June 30, 2011. When the Company has lower sales in the quarter, production staff personnel are used for the further development of the Company’s product lines.

 

10


Table of Contents

Other Income (Expense): For the quarter ended June 30, 2012 interest expense was $61,000 compared to $38,000 of interest expense for the quarter ended June 30, 2011.

Net Income (Loss): Significantly lower revenues in the quarter ended June 30, 2012 account for net loss of $630,000 compared to a net loss of $597,000 for the quarter ended June 30, 2011.

Nine months ended June 30, 2012 compared to the nine months ended June 30, 2011

Revenues: Revenues for the nine months ended June 30, 2012 were $1,200,000 compared to revenues of $6,323,000 for the nine months ended June 30, 2011. For the nine months ended June 30, 2012, 84% of revenues were from sales of our NightHunter products to the military (U.S. Army, U.S. Marines and military distributors) and 16% were from sales of SuperVision units. For the nine months ended June 30, 2011, 95% of revenues were from sales of our NightHunter products to the military market.

Cost of Goods and Gross Profit: Cost of goods consist of the cost of manufacturing our NightHunter One and SuperVision products and the price that we pay to Excelitas Technologies (formerly PerkinElmer) for NightHunter 3 products that Excelitas Technologies manufactures for us.

The gross profit percentages were 38% and 45% for the nine months ended June 30, 2012 and 2011, respectively. The gross profit percentage for the nine months ended June 30, 2012 was negatively impacted by significantly lower sales.

Selling, General and Administrative: Selling, general and administrative expenses decreased by $291,000 to $1,587,000 for the nine months ended June 30, 2012 as compared to $1,878,000 for the nine months ended June 30, 2011. The reduction is primarily attributable to decreases in compensation and benefits of $82,000, consulting expenses of $100,000, legal expenses of $44,000 and other sales and outside services expenses of $45,000, offset by an increase in non-cash compensation expenses for warrants of $25,000.

Research & Development: Research and development expenses were $588,000 for the nine months ended June 30, 2012 compared to $495,000 for the nine months ended June 30, 2011. When the Company has lower sales, production staff personnel are used for the further development of the Company’s product lines.

Net Income (Loss): Significantly lower revenues for the nine month period ended June 30, 2012 accounted for a net loss of $1,857,000 compared to net income of $377,000 for the nine-month months ended June 30, 2011.

Liquidity and Capital Resources

As of June 30, 2012, the Company had working capital of $893,000 and a current ratio of 1.4 to 1 as compared to working capital of $3,088,000 and a current ratio of 6.1 to 1 as of September 30, 2011. Current liabilities at June 30, 2012 include notes payable of $1,522,000 that are now due on October 15, 2012 and December 31, 2012.

Our net loss of $1,857,000 for the nine months ended June 30, 2012 negatively impacted cash. Significant sources of cash provided by operating activities during the first nine months of the current year included non-cash compensation for warrants issued and modified of $30,000, non-cash compensation to consultants of $74,000, amortization of warrants for notes payable of $62,000 and a decrease in inventories of $316,000, offset by a decrease in accounts receivable of $50,000. Cash used in operating activities totaled $1,436,000 for the nine months ended June 30, 2012.

 

11


Table of Contents

Cash flows from financing activities included the proceeds of a note payable. On March 19, 2012 the Company borrowed $500,000 with interest of $50,000 due not later than December 31, 2012. On May 22, 2012 the Company borrowed $500,000 with interest of $50,000 due not later than December 31, 2012.

Our financial statements for the three and nine months ended June 30, 2012 include an explanatory paragraph relating to our ability to continue as a going concern. Based on the amount of working capital that we had on hand on June 30, 2012 and the amount of unfilled and potential orders we have pending, we are optimistic about our ability to obtain sales orders and/or additional equity or debt financing to continue to support planned operations and satisfy obligations. However, due to the nature of our business, there is no assurance that we will receive new orders during the quarters that we expect them and although management believes it can obtain additional financing, there is no certainty that it can.

 

12


Table of Contents
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable

 

ITEM 4. Controls and Procedures

The Company’s management conducted an evaluation, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness as of the end of the period covered by this quarterly report of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”). Disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”) and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of June 30, 2012, which is the end of the period covered by this quarterly report.

Based upon our evaluation, we also concluded that there was no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

13


Table of Contents

PART II. OTHER INFORMATION

 

ITEM 6. Exhibits

 

Exhibit

    

Number

  

Description

31.1    Certification of the Chairman of the Board and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
31.2    Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
32.1    Certification pursuant to Section 906 of the Sarbanes-Oxley Act
32.2    Certification pursuant to Section 906 of the Sarbanes-Oxley Act
101    The following financial information from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, formatted in XBRL (eXtensible Business Reporting Language): (1) Condensed Consolidated Balance Sheets as of June 30, 2012 and September 30, 2011; (2) Condensed Consolidated Statements of Operations for the three and nine months ended June 30, 2012 and 2011; (3) Condensed Consolidated Statements of Cash Flows for the nine months ended June 30, 2012 and 2011; and (4) Notes to Financial Statements.*

 

* Pursuant to Rule 406T of Regulation S-T, the information in Exhibit 101 (a) is “furnished” and is not deemed to be “filed” or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, (b) is deemed not to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and (c) is not otherwise subject to liability under those sections.

 

14


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      XENONICS HOLDINGS, INC.
Date: August 14, 2012     By:   /s/ Alan P. Magerman
      Alan P. Magerman
     

Chairman of the Board

Chief Executive Officer

Date: August 14, 2012     By:   /s/ Richard S. Kay
      Richard S. Kay
      Chief Financial Officer

 

15